Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study

1464OCLINICAL VALUE OF CIRCULATING TUMOR CELLS IN MONITORING TREATMENT RESPONSE IN CHINESE PATIENTS WITH SMALL CELL LUNG CANCER

(2017) Y. Cheng et al.   ANNALS OF ONCOLOGY

Circulating tumor cell counts/change for outcome prediction in patients with extensive-stage small-cell lung cancer

(2016) Ying Cheng et al.   Future Oncology

Elevated expression of CXCR4 and correlation with clinicopathological features and prognosis of non-small cell lung cancer patients: a meta-analysis

(2015) H. Wang et al.   GENETICS AND MOLECULAR RESEARCH

PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma

(2015) Jennifer D. Kubic et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

CXCR4 over-expression and survival in cancer: A system review and meta-analysis

(2015) Hongli Zhao et al.   Oncotarget

A Phase I Trial of LY2510924, a CXCR4 Peptide Antagonist, in Patients with Advanced Cancer

(2014) M. D. Galsky et al.   CLINICAL CANCER RESEARCH

Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor–Positive Breast Cancer

(2014) Costanza Paoletti et al.   CLINICAL CANCER RESEARCH

Prognostic value of circulating tumor cells’ reduction in patients with extensive small-cell lung cancer

(2014) Nicola Normanno et al.   LUNG CANCER

Identification of LY2510924, a Novel Cyclic Peptide CXCR4 Antagonist That Exhibits Antitumor Activities in Solid Tumor and Breast Cancer Metastatic Models

(2014) S.-B. Peng et al.   MOLECULAR CANCER THERAPEUTICS

Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer

(2014) Cassandra L Hodgkinson et al.   NATURE MEDICINE

Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor

(2012) T. J. N. Hiltermann et al.   ANNALS OF ONCOLOGY

Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer

(2012) Jian-Mei Hou et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Impact of Circulating Tumor Cells in Patients with Small Cell Lung Cancer

(2012) Tateaki Naito et al.   Journal of Thoracic Oncology

Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin

(2012) Martin Reck et al.   LUNG CANCER

CXCL12 (SDF-1)/CXCR4 Pathway in Cancer

(2010) B. A. Teicher et al.   CLINICAL CANCER RESEARCH

Preliminary Investigation of the Clinical Significance of Detecting Circulating Tumor Cells Enriched from Lung Cancer Patients

(2010) Chi Wu et al.   Journal of Thoracic Oncology

Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy

(2009) Jian-Mei Hou et al.   AMERICAN JOURNAL OF PATHOLOGY

CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer

(2009) Karen L Reckamp et al.   BMC CANCER

A “live” biopsy in a small-cell lung cancer patient by detection of circulating tumor cells

(2009) Simona Bevilacqua et al.   LUNG CANCER

Expression of the chemokine receptor CXCR4 correlates with a favorable prognosis in patients with adenocarcinoma of the lung

(2009) Yoshihiro Minamiya et al.   LUNG CANCER

CXCR4 expression heterogeneity in neuroblastoma cells due to ligand-independent regulation

(2009) Alex J Carlisle et al.   Molecular Cancer